Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders

The BNT162b2 mRNA COVID-19 vaccine is safe and well-tolerated in patients with mast cell disorders. These patients can be immunized with this vaccine with no need for specific measures.

Automated summary

Patients with mast cell disorders can safely receive the BNT162b2 mRNA COVID-19 vaccine without the need for specific measures.